Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease.
Clin J Am Soc Nephrol
; 13(8): 1153-1161, 2018 08 07.
Article
en En
| MEDLINE
| ID: mdl-30026287
Palabras clave
ADPKD; Benzazepines; EGFR protein, human; Follow-Up Studies; Humans; Polycystic Kidney, Autosomal Dominant; Receptor, Epidermal Growth Factor; Renal Insufficiency, Chronic; Renal Replacement Therapy; TEMPO; Tolvaptan; Vasopressin Receptor Antagonist; chronic kidney disease; glomerular filtration rate; polycystic kidney disease; vasopressin
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Riñón Poliquístico Autosómico Dominante
/
Antagonistas de los Receptores de Hormonas Antidiuréticas
/
Tolvaptán
/
Tasa de Filtración Glomerular
Tipo de estudio:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2018
Tipo del documento:
Article